In
Articles
ASCO GU 2019: Gemcitabine + Axitinib Shows Promising Efficacy in Sarcomatoid Renal Cell Carcinoma
PracticeUpdate Editorial Team
Published in Oncology
News – February 20, 2019
Though confirmation is needed, gemcitabine may come to be considered a treatment option for sarcomatoid renal cell carcinoma.
Read article
Sorry, the comment form is closed at this time.